• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳头状肾细胞癌的多模态成像特征

Multimodality Imaging Features of Papillary Renal Cell Carcinoma.

作者信息

Comune Rosita, Tiralongo Francesco, Bicci Eleonora, Saturnino Pietro Paolo, Ronza Francesco Michele, Bortolotto Chandra, Granata Vincenza, Masala Salvatore, Scaglione Mariano, Sica Giacomo, Tamburro Fabio, Tamburrini Stefania

机构信息

Department of Radiology, Ospedale del Mare-ASL NA1 Centro-Napoli, 80147 Naples, Italy.

Radiology Unit 1, Department of Medical Surgical Sciences and Advanced Technologies "GF Ingrassia", University Hospital Policlinico "G. Rodolico-San Marco", University of Catania, 95123 Catania, Italy.

出版信息

Diagnostics (Basel). 2025 Apr 1;15(7):906. doi: 10.3390/diagnostics15070906.

DOI:10.3390/diagnostics15070906
PMID:40218256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11988733/
Abstract

To describe the US, CEUS, CT, and MRI features of papillary renal cell carcinoma (PRCC) and to underline the imaging characteristics that are helpful in the differential diagnosis. Patients with histologically proven papillary renal cell carcinoma who underwent at least two imaging examinations (US, CEUS, CT, and MRI) were included in the study. Tumor size, homogeneity, morphology, perilesional stranding, contrast enhancement locoregional extension were assessed. A comparison and the characteristics of the imaging features for each imaging modality were analyzed. A total of 27 patients with an histologically confirmed diagnosis of PRCC were included in the study. US was highly accurate in distinguishing solid masses from cystic masses, supporting the differential diagnosis of PRCC, as well as in patients with a poor representation of the solid component. CEUS significantly increased diagnostic accuracy in delineating the solid intralesional component. Furthermore, when using CEUS, in the arterial phase, PRCC exhibited hypo-enhancement, and in the late phase it showed an inhomogeneous and delayed wash-out compared with the surrounding renal parenchyma. At MRI, PRCC showed a marked restiction of DWI and was hypointense in the T2-weighted compared to the renal parenchyma. In our study, the characteristic hypodensity and hypoenhancement of PRCC make CT the weakest method of their recognition, while US/CEUS and MRI are necessary to reach a definitive diagnosis. Knowledge of the appearance of PRCC can support an early diagnosis and prompt management, and radiologists should be aware that PRCC, when detected using CT, may resemble spurious non-septate renal cyst.

摘要

描述乳头状肾细胞癌(PRCC)的超声(US)、超声造影(CEUS)、计算机断层扫描(CT)和磁共振成像(MRI)特征,并强调有助于鉴别诊断的影像学特征。纳入经组织学证实为乳头状肾细胞癌且至少接受过两项影像学检查(US、CEUS、CT和MRI)的患者。评估肿瘤大小、均匀性、形态、病灶周围条索状影、对比增强及局部扩展情况。分析每种影像学检查方法的成像特征并进行比较。本研究共纳入27例经组织学确诊为PRCC的患者。US在区分实性肿块与囊性肿块方面具有高度准确性,有助于PRCC的鉴别诊断,对于实性成分显示不佳的患者也是如此。CEUS在勾画病灶内实性成分方面显著提高了诊断准确性。此外,使用CEUS时,PRCC在动脉期表现为低增强,在延迟期与周围肾实质相比表现为不均匀且延迟消退。在MRI上,PRCC在扩散加权成像(DWI)上表现为明显受限,在T2加权像上相对于肾实质呈低信号。在我们的研究中,PRCC的特征性低密度和低增强使CT成为识别它们的最弱方法,而US/CEUS和MRI对于明确诊断是必要的。了解PRCC的表现有助于早期诊断和及时治疗,放射科医生应意识到,使用CT检测到的PRCC可能类似于假性无分隔肾囊肿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/b53002a6fe04/diagnostics-15-00906-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/26e063468c30/diagnostics-15-00906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/f3e3a02ce3f8/diagnostics-15-00906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/684bcc0a87d4/diagnostics-15-00906-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/4c5abf9cb537/diagnostics-15-00906-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/2e702e0b8742/diagnostics-15-00906-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/9b83acf5d1d7/diagnostics-15-00906-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/0eef3fd5b48b/diagnostics-15-00906-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/c0ef1828bd3f/diagnostics-15-00906-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/b53002a6fe04/diagnostics-15-00906-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/26e063468c30/diagnostics-15-00906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/f3e3a02ce3f8/diagnostics-15-00906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/684bcc0a87d4/diagnostics-15-00906-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/4c5abf9cb537/diagnostics-15-00906-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/2e702e0b8742/diagnostics-15-00906-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/9b83acf5d1d7/diagnostics-15-00906-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/0eef3fd5b48b/diagnostics-15-00906-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/c0ef1828bd3f/diagnostics-15-00906-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6c/11988733/b53002a6fe04/diagnostics-15-00906-g009.jpg

相似文献

1
Multimodality Imaging Features of Papillary Renal Cell Carcinoma.乳头状肾细胞癌的多模态成像特征
Diagnostics (Basel). 2025 Apr 1;15(7):906. doi: 10.3390/diagnostics15070906.
2
Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.乳头状肾细胞癌和透明细胞肾细胞癌:用超声造影鉴别不同组织学类型。
Eur J Radiol. 2015 Oct;84(10):1849-56. doi: 10.1016/j.ejrad.2015.06.017. Epub 2015 Jun 25.
3
Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.Xp11.2 易位/TFE3 基因融合相关性成人肾细胞癌的超声造影表现:与透明细胞肾细胞癌和乳头状肾细胞癌的比较。
Cancer Imaging. 2019 Dec 31;20(1):1. doi: 10.1186/s40644-019-0268-7.
4
Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) - A diagnostic performance study.超声造影(CEUS)在乳头状肾细胞癌中的应用——一项诊断性能研究。
Clin Hemorheol Microcirc. 2019;71(2):159-164. doi: 10.3233/CH-189406.
5
Routine or enhanced imaging to differentiate between type 1 and type 2 papillary renal cell carcinoma.常规或增强成像以区分 1 型和 2 型乳头状肾细胞癌。
Clin Radiol. 2021 Feb;76(2):135-142. doi: 10.1016/j.crad.2020.09.020. Epub 2020 Oct 19.
6
The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.实时超声造影联合 CT 增强在肾细胞癌亚型鉴别诊断中的价值。
Urol Oncol. 2021 Dec;39(12):837.e19-837.e28. doi: 10.1016/j.urolonc.2021.09.004. Epub 2021 Oct 12.
7
Role of Contrast-Enhanced Ultrasound With the Enhancement Pattern and Qualitative Analysis for Differentiating Hypovascular Solid Renal Lesions.超声造影结合增强模式及定性分析在鉴别乏血供实性肾病变中的作用
Ultrasound Med Biol. 2024 Feb;50(2):295-303. doi: 10.1016/j.ultrasmedbio.2023.11.002. Epub 2023 Nov 23.
8
[Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings].基于CT和MRI表现的XP11.2易位/TFE基因融合相关性肾细胞癌与乳头状肾细胞癌的鉴别诊断
Zhonghua Yi Xue Za Zhi. 2014 May 20;94(19):1470-2.
9
Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.利用对比增强MDCT和FSE T2加权MRI图像对透明细胞和乳头状肾细胞癌进行肿瘤分级评估:放射学与病理学相关性研究
Radiol Med. 2021 Sep;126(9):1139-1148. doi: 10.1007/s11547-021-01350-y. Epub 2021 Jun 7.
10
Comparative study of CT and MRI appearances in mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.黏液性管状和梭形细胞癌与乳头状肾细胞癌的 CT 和 MRI 表现的对比研究。
Br J Radiol. 2021 Oct 1;94(1126):20210548. doi: 10.1259/bjr.20210548. Epub 2021 Sep 3.

本文引用的文献

1
The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates.世界卫生组织《2022年肾肿瘤分类》(第5版):重要更新
Cureus. 2024 Apr 17;16(4):e58470. doi: 10.7759/cureus.58470. eCollection 2024 Apr.
2
A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.一项基于人群的研究显示,2000 年至 2020 年期间美国肾和肾盂癌的发病率趋势。
Sci Rep. 2024 May 17;14(1):11294. doi: 10.1038/s41598-024-61748-2.
3
Gross hematuria: Renal cell carcinoma mimicking a renal arteriovenous malformation.
肉眼血尿:肾细胞癌酷似肾动静脉畸形。
Radiol Case Rep. 2024 Mar 10;19(6):2130-2134. doi: 10.1016/j.radcr.2024.02.034. eCollection 2024 Jun.
4
Scientific Status Quo of Small Renal Lesions: Diagnostic Assessment and Radiomics.小肾病变的科学现状:诊断评估与放射组学
J Clin Med. 2024 Jan 18;13(2):547. doi: 10.3390/jcm13020547.
5
Papillary Renal Cell Carcinoma: Demographics, Survival Analysis, Racial Disparities, and Genomic Landscape.乳头状肾细胞癌:人口统计学、生存分析、种族差异及基因组格局
J Kidney Cancer VHL. 2023 Dec 26;10(4):33-42. doi: 10.15586/jkcvhl.v10i4.294. eCollection 2023.
6
Abdominal Emergencies in Cancer Patients.癌症患者的腹部急症
Can Assoc Radiol J. 2024 Feb;75(1):161-170. doi: 10.1177/08465371231175521. Epub 2023 May 16.
7
MDCT Diagnosis and Staging of Xanthogranulomatous Pyelonephritis.黄色肉芽肿性肾盂肾炎的多层螺旋CT诊断与分期
Diagnostics (Basel). 2023 Apr 4;13(7):1340. doi: 10.3390/diagnostics13071340.
8
What's new in the WHO 2022 classification of kidney tumours?世界卫生组织 2022 年版肾脏肿瘤分类有哪些新内容?
Pathologica. 2022 Feb;115(1):8-22. doi: 10.32074/1591-951X-818. Epub 2023 Jan 16.
9
Papillary Renal Cell Carcinoma As An Abdominal Cystic Mass.乳头状肾细胞癌表现为腹部囊性肿块。
J Ayub Med Coll Abbottabad. 2022 Oct-Dec;34(4):891-894. doi: 10.55519/JAMC-04-10865.
10
Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.晚期乳头状肾细胞癌:流行病学、基因组驱动因素、当前治疗方法及正在进行的试验。
Cancer Treat Res Commun. 2022;33:100639. doi: 10.1016/j.ctarc.2022.100639. Epub 2022 Sep 22.